https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Alpine_Immune_Sciences%2C_Inc.Alpine Immune Sciences, Inc. - Revizia istoricului2026-04-10T12:58:34ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Alpine_Immune_Sciences,_Inc.&diff=405907&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Alpine Immune Sciences, Inc. listata cu simbolul US.ALPN ==Descriere companie== Alpine Immune Sciences, Inc. (www.alpineimmunesciences.com) is a biopharmaceutical company. The Company is focused on discovering and developing protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The Company's scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super f...2024-09-18T13:36:57Z<p>Pagină nouă: Pagina dedicata companiei Alpine Immune Sciences, Inc. listata cu simbolul US.ALPN ==Descriere companie== Alpine Immune Sciences, Inc. (www.alpineimmunesciences.com) is a biopharmaceutical company. The Company is focused on discovering and developing protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The Company's scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super f...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Alpine Immune Sciences, Inc. listata cu simbolul US.ALPN<br />
<br />
==Descriere companie==<br />
Alpine Immune Sciences, Inc. (www.alpineimmunesciences.com) is a biopharmaceutical company. The Company is focused on discovering and developing protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The Company's scientific platform uses a directed evolution process to convert native immune system proteins from the immunoglobulin super family (IgSF) into multi-targeted therapeutics capable of modulating the human immune system. Its product candidates include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulator (ICOS) and cluster of differentiation 28 (CD28) antagonist intended for the treatment of autoimmune and inflammatory diseases. Its oncology program is ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor intended for the treatment of cancer. ALPN-303 is a dual B-cell cytokine antagonist for the treatment of B-cell mediated diseases.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.ALPN" /><br />
<br />
==Ultimele stiri despre Alpine Immune Sciences, Inc. (US.ALPN)==<br />
<dynamicpagelist><br />
category=US.ALPN<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.ALPN]][[Categorie:Stiri despre companii]]</div>Admin